Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373766 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
Exploration of the SAR around a series of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines led to the discovery of novel pyrrolopyridine inhibitors of the IGF-1R tyrosine kinase. Several compounds demonstrated nanomolar potency in enzyme and cellular mechanistic assays.
Graphical abstractExploration of the SAR around a series of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines led to the discovery of novel pyrrolopyridines as nanomolar inhibitors of the IGF-1R tyrosine kinase.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Samarjit Patnaik, Kirk L. Stevens, Roseanne Gerding, Felix Deanda, J. Brad Shotwell, Jun Tang, Toshihiro Hamajima, Hiroko Nakamura, M. Anthony Leesnitzer, Anne M. Hassell, Lisa M. Shewchuck, Rakesh Kumar, Huangshu Lei, Stanley D. Chamberlain,